MegaRobo Raises Nearly $200 Million for Physical AI Infrastructure
MegaRobo raised nearly $200 million for AI infrastructure that runs real experiments, lifting total funding to about $600 million. It serves 500+ pharma and research institutions.
By Grace Kim
3 min read

What's News
- MegaRobo raised nearly $200 million, bringing cumulative funding to about $600 million.
- The company has delivered technology to more than 500 pharma, biotech and research customers.
- Its Megalaxy Lab platform has served more than 200 customers.
- MegaRobo partnered with Tencent Cloud and Twist Bioscience on Poreva Open, validating over 10,000 protein sequences.
MegaRobo has raised nearly $200 million to build infrastructure that connects AI systems to scientific experiments and other complex physical environments. The round brings the company's cumulative funding to approximately $600 million.
The Beijing-based automation specialist plans to spend the money in three directions: investing in its core technology, expanding its AI-for-science business internationally, and continuing to develop infrastructure that lets AI execute tasks and learn from real-world feedback.
What is MegaRobo actually building?
The centerpiece is what the company calls its One Intelligence Stack. It brings together models, agents, scientific data, software, laboratory instruments, robotics, automation, and physical feedback — the full chain from a model's output to a robot's action and back.
MegaRobo is applying the architecture first to scientific discovery and pharmaceutical research. Its products cover early research, target discovery, mechanism studies, drug screening, and candidate optimization — the preclinical pipeline from idea to drug candidate.
The traction is measurable. The company has delivered technology to more than 500 pharmaceutical companies, biotechnology businesses, drug-discovery organizations, and research institutions.
Its flagship Megalaxy Lab lets researchers and AI agents configure experiments, submit them to automated laboratory systems, monitor execution, and receive structured results. That platform alone has served more than 200 customers.
In short: MegaRobo has already crossed from prototype into paid deployment at scale.
Why does the bet on "physical AI" matter?
Founder and CEO Daniel Huang frames the round around a generational shift in how AI learns. He said:
"The first generation of AI learned from humanity's accumulated knowledge. The next generation will increasingly learn by acting in the physical world – through experiments, production and continuous feedback. That shift changes AI from a system that interprets the world into one that can help create new knowledge, materials, processes and products. MegaRobo is building the infrastructure for that transition."
Huang's argument is simple: models trained on text and images are running out of accumulated human knowledge to consume. Experiments, production lines and continuous physical feedback are the next training substrate — and whoever builds the plumbing for that stands to own a critical layer.
Who backed the round?
Asia Investment Capital is among the investors, and its founding partner and CEO, Liu Erh Fei, explained the firm's conviction:
"As a long-term shareholder, we have seen MegaRobo continuously drive innovation, earn the trust of its customers and translate its technological capabilities into commercial applications. Its ability to integrate AI, software and hardware, together with its experience in scientific research and advanced manufacturing, underpins our continued investment. We look forward to continuing to support MegaRobo as it further strengthens its product and technology platforms and serves more customers worldwide."
The emphasis on integration — AI plus software plus hardware — signals what investors are actually underwriting: not a model, but a system that can survive contact with physical labs.
What comes next?
MegaRobo has also partnered with Tencent Cloud and Twist Bioscience on Poreva Open, a protein-design challenge that will provide laboratory validation for more than 10,000 sequences. That project doubles as a public proof point: AI-designed proteins checked against real wet-lab results at four-digit scale.
With roughly $600 million raised to date, an international expansion on the agenda, and 500-plus institutions already on its customer list, MegaRobo is now positioned to test whether the market for AI that acts in the physical world grows as fast as the market for AI that merely talks about it.
Source: pulse2.com
More from Grace Kim
Show full bio
Market editor covering people, launches and day-to-day practice in entrepreneurship, startups and venture funding at Business Bearings.
2,447 articles